Turning Discovery into Treatment
The Center for Human Therapeutics (CHT) at the University of Virginia advances promising research from the laboratory into clinical practice. Our cGMP-compliant facility supports the manufacturing of biologics and cellular therapies for first-in-human, pilot, and Phase I/II clinical trials.
What We Do
We manufacture and process a broad range of investigational products for human clinical use, including:
Beyond manufacturing, we provide scientific, technical, and regulatory support for investigator-initiated IND applications — helping researchers navigate the path from preclinical data to clinical study.
Areas of Focus
Our work spans cancer — including multiple myeloma, breast, prostate, pancreatic, and brain cancers — as well as a growing range of non-oncology indications such as cardiovascular disease, autoimmune conditions, diabetes, and neurological disorders.
CHT operates a dedicated, multi-use cleanroom complex designed and built to FDA standards for controlled environments and aseptic processing. The facility includes six ISO 7 manufacturing rooms, a controlled-access corridor, and dedicated office and support space.
